Announced
Completed
Financials
Tags
Electronic Components and Equipment
Completed
France
Medical Equipment
cardiovascular robotic systems
Private
Minority
Private Equity
Acquisition
Friendly
medical instrumentation
Cross Border
Synopsis
MicroPort Scientific, a developer, manufacturer and operator of intervention products for the treatment of vascular diseases, led a $43m Series C funding round of Robocath, a designer and developer of cardiovascular robotic systems. Zhejiang Silk Road Fund, TUS-Holdings, CS Group and Anaxago also participated in the round. “This financial round gives Robocath the resources to achieve its overall ambitions. MicroPort’s commitment demonstrates the relevance of our value proposition. Thanks to the excellent technological and commercial synergies between our companies, we will accelerate our development and together build a great future in the vascular robotic field. This will benefit patients, physicians and ultimately healthcare systems,” Lucien Goffart, Robocath CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.